JP2008505644A - 食道癌、結腸癌、頭頸部癌、およびメラノーマにおけるマーカーの同定 - Google Patents

食道癌、結腸癌、頭頸部癌、およびメラノーマにおけるマーカーの同定 Download PDF

Info

Publication number
JP2008505644A
JP2008505644A JP2007520520A JP2007520520A JP2008505644A JP 2008505644 A JP2008505644 A JP 2008505644A JP 2007520520 A JP2007520520 A JP 2007520520A JP 2007520520 A JP2007520520 A JP 2007520520A JP 2008505644 A JP2008505644 A JP 2008505644A
Authority
JP
Japan
Prior art keywords
mrna species
specific
excess
lymph nodes
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007520520A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008505644A5 (enExample
Inventor
ゴドフリー,トニー・イー
シー,リキアン
ラジャ,シヴァ
ヒューズ,スティーヴン・ジェイ
グディング,ウィリアム・イー
Original Assignee
ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション filed Critical ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション
Publication of JP2008505644A publication Critical patent/JP2008505644A/ja
Publication of JP2008505644A5 publication Critical patent/JP2008505644A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2007520520A 2004-07-09 2005-07-08 食道癌、結腸癌、頭頸部癌、およびメラノーマにおけるマーカーの同定 Pending JP2008505644A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58659904P 2004-07-09 2004-07-09
US58701904P 2004-07-09 2004-07-09
PCT/US2005/024194 WO2006017151A2 (en) 2004-07-09 2005-07-08 Identification of makers in esophageal cancer, colon cancer, head and neck cancer and melanoma

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011190962A Division JP2012005500A (ja) 2004-07-09 2011-09-01 食道癌、結腸癌、頭頸部癌、およびメラノーマにおけるマーカーの同定

Publications (2)

Publication Number Publication Date
JP2008505644A true JP2008505644A (ja) 2008-02-28
JP2008505644A5 JP2008505644A5 (enExample) 2008-08-21

Family

ID=35839738

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007520520A Pending JP2008505644A (ja) 2004-07-09 2005-07-08 食道癌、結腸癌、頭頸部癌、およびメラノーマにおけるマーカーの同定
JP2007520519A Pending JP2008510454A (ja) 2004-07-09 2005-07-08 肺癌および乳癌におけるマーカーの同定
JP2011190962A Withdrawn JP2012005500A (ja) 2004-07-09 2011-09-01 食道癌、結腸癌、頭頸部癌、およびメラノーマにおけるマーカーの同定

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2007520519A Pending JP2008510454A (ja) 2004-07-09 2005-07-08 肺癌および乳癌におけるマーカーの同定
JP2011190962A Withdrawn JP2012005500A (ja) 2004-07-09 2011-09-01 食道癌、結腸癌、頭頸部癌、およびメラノーマにおけるマーカーの同定

Country Status (6)

Country Link
US (4) US7662561B2 (enExample)
EP (6) EP1774025A4 (enExample)
JP (3) JP2008505644A (enExample)
AU (2) AU2005271960B2 (enExample)
CA (2) CA2571642A1 (enExample)
WO (2) WO2006017150A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011078223A1 (ja) * 2009-12-24 2011-06-30 国立大学法人愛媛大学 頸部リンパ節転移分析方法及び頭頸部癌の腫瘍マーカー

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050112622A1 (en) 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
EP1774025A4 (en) * 2004-07-09 2009-09-16 Univ Pittsburgh IDENTIFYING MARKERS IN LUNG AND BREAST CANCER
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
JP2008515393A (ja) * 2004-09-20 2008-05-15 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 複数モードの多重化反応消去方法
JP4968577B2 (ja) * 2006-04-11 2012-07-04 エフ.ホフマン−ラ ロシュ アーゲー サイトケラチン19(CK19)mRNAの迅速測定法、並びにそのためのプライマー及びプローブ
US8119352B2 (en) * 2006-06-20 2012-02-21 Cepheld Multi-stage amplification reactions by control of sequence replication times
JP4943074B2 (ja) * 2006-07-03 2012-05-30 シスメックス株式会社 がん転移の判定方法及び装置
US7622456B2 (en) * 2006-11-06 2009-11-24 Non-Profit Organization Chang Gung Memorial Hospital Method on clinical applications in head neck cancer by using DSG3 molecule for predicting malignant degree of cancer, serving as a molecular target and using RNA jamming sequence on inhibition-specific of DSG3 expression
CA2669600A1 (en) * 2006-11-13 2008-05-29 Source Precision Medicine, Inc. D/B/A Source Mdx Gene expression profiling for identification, monitoring, and treatment of lung cancer
US9151762B2 (en) 2009-06-12 2015-10-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Identification of DSG-3 as a biomarker for the detection of metastasis in lymph nodes
EP2516429B1 (en) 2009-12-22 2020-06-24 Avon Products, Inc. Paxillin stimulating compositions and cosmetic uses thereof
EP2659004B1 (en) 2010-12-30 2017-08-30 Avon Products, Inc. Modulation of dynein in skin
US9771617B2 (en) 2011-06-27 2017-09-26 Eisai R&D Management Co., Ltd. Microrna biomarkers indicative of alzheimer's disease
US10195136B2 (en) 2011-08-24 2019-02-05 Avon Products, Inc. Collagen and elastin stimulating compositions and uses thereof
US8709507B2 (en) 2011-12-13 2014-04-29 Avon Products, Inc. Maesa japonica extracts and methods of use
US8632827B2 (en) 2011-12-13 2014-01-21 Avon Products, Inc Modulation of thymosin beta-4 in skin
JP2013208420A (ja) * 2012-03-02 2013-10-10 Nippon Koden Corp 心電図解析レポート、心電図解析装置及び心電図解析プログラム
JP6419694B2 (ja) * 2012-06-29 2018-11-07 デピュイ・シンセス・プロダクツ・インコーポレイテッド 横方向挿入脊椎インプラント
CN108949992B (zh) * 2018-08-14 2021-11-05 高鑫 一种与食管鳞癌及其分级相关的生物标志物
CN109913552B (zh) * 2019-03-27 2020-08-04 河北医科大学第四医院 一种食管鳞癌诊疗靶点及应用
EP4116435A1 (en) * 2021-07-08 2023-01-11 Universidad de Granada In vitro method for the diagnosis and/or prognosis of malignant melanoma
WO2023081988A1 (pt) * 2021-11-09 2023-05-19 Coelho Guilherme Portela Método para predição de eficácia de tratamento para câncer de mama

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5274087A (en) 1986-08-13 1993-12-28 Molecular Diagnostics, Inc. cDNA coding for carcinoembryonic antigen (CEA)
US6379895B1 (en) * 1989-06-07 2002-04-30 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6406844B1 (en) * 1989-06-07 2002-06-18 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
ES2091976T3 (es) * 1991-06-20 1996-11-16 Hoffmann La Roche Metodos perfeccionados para la amplificacion del acido nucleico.
US6309823B1 (en) 1993-10-26 2001-10-30 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same
EP0732929B1 (en) 1993-10-29 2008-05-14 The Brigham And Women's Hospital, Inc. Therapeutic use of cis-element decoys in vivo
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
AU5310296A (en) 1995-03-17 1996-10-08 John Wayne Cancer Institute Detection of melanoma or breast metastases with a multiple marker assay
JP4484967B2 (ja) 1995-06-06 2010-06-16 ベス イスラエル ディーコネス メディカル センター Dna診断試験の方法及び装置
US5882856A (en) 1995-06-07 1999-03-16 Genzyme Corporation Universal primer sequence for multiplex DNA amplification
US6031129A (en) * 1995-10-03 2000-02-29 Quantum Chemical Corporation Use of pentavalent group VA oxides in acetic acid processing
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US5837442A (en) * 1995-11-29 1998-11-17 Roche Molecular Systems, Inc. Oligonucleotide primers for amplifying HCV nucleic acid
AUPO188396A0 (en) 1996-08-26 1996-09-19 Insearch Limited Detection of protozoan parasites
US5958349A (en) 1997-02-28 1999-09-28 Cepheid Reaction vessel for heat-exchanging chemical processes
US5843721A (en) 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
GB9719044D0 (en) 1997-09-08 1997-11-12 Inst Of Ophthalmology Assay
EP1179585B1 (en) 1997-12-24 2008-07-09 Cepheid Device and method for lysis
US6660228B1 (en) 1998-03-02 2003-12-09 Cepheid Apparatus for performing heat-exchanging, chemical reactions
US6037129A (en) * 1998-05-28 2000-03-14 Medical University Of South Carolina Multi-marker RT-PCR panel for detecting metastatic breast cancer
US6306643B1 (en) 1998-08-24 2001-10-23 Affymetrix, Inc. Methods of using an array of pooled probes in genetic analysis
US6245517B1 (en) 1998-09-29 2001-06-12 The United States Of America As Represented By The Department Of Health And Human Services Ratio-based decisions and the quantitative analysis of cDNA micro-array images
US6431476B1 (en) 1999-12-21 2002-08-13 Cepheid Apparatus and method for rapid ultrasonic disruption of cells or viruses
EP1146869A2 (en) 1999-01-27 2001-10-24 University Of South Florida Inhibition of stat3 signal transduction for human cancer therapy
US6251601B1 (en) 1999-02-02 2001-06-26 Vysis, Inc. Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays
US6300069B1 (en) 1999-05-03 2001-10-09 Qiagen Gmbh Generation and amplification of nucleic acids from ribonucleic acids
EP1208189B1 (en) 1999-05-28 2004-10-06 Cepheid Device and method for analysing liquid samples
ATE333938T1 (de) 1999-05-28 2006-08-15 Cepheid Patrone zum durchführen einer chemischen reaktion
SE9902410D0 (sv) 1999-06-24 1999-06-24 Cavidi Tech Ab Reverse transcriptase assay kit, use thereof and method for analysis of RT activity in biological samples
AU5830400A (en) * 1999-06-30 2001-01-22 Arto Orpana Diagnostic method for squamous cell carcinoma
US6403037B1 (en) 2000-02-04 2002-06-11 Cepheid Reaction vessel and temperature control system
US6844153B2 (en) * 2000-03-27 2005-01-18 Thomas Jefferson University Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
US6783934B1 (en) 2000-05-01 2004-08-31 Cepheid, Inc. Methods for quantitative analysis of nucleic acid amplification reaction
US20020168647A1 (en) * 2000-08-03 2002-11-14 Tongtong Wang Compositions and methods for the therapy and diagnosis of head and neck cancer
US6374684B1 (en) 2000-08-25 2002-04-23 Cepheid Fluid control and processing system
US8048386B2 (en) 2002-02-25 2011-11-01 Cepheid Fluid processing and control
WO2002037113A2 (en) * 2000-11-03 2002-05-10 Michael Giesing Clinical and functional validation of targets from disseminated cancer cells
US6312929B1 (en) 2000-12-22 2001-11-06 Cepheid Compositions and methods enabling a totally internally controlled amplification reaction
CA2439402A1 (en) 2001-03-02 2002-09-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pcr method
EP1464695A1 (en) 2001-12-26 2004-10-06 Olympus Corporation Reaction vessel and reaction vessel holding mechanism
US6819027B2 (en) 2002-03-04 2004-11-16 Cepheid Method and apparatus for controlling ultrasonic transducer
EP2261368A1 (en) * 2002-03-13 2010-12-15 Genomic Health, Inc. Gene expression profiling in biopsied tumor tissues
CN1659287A (zh) * 2002-04-05 2005-08-24 美国政府健康及人类服务部 诊断肝癌转移或发病可能性及鉴定治疗靶点的方法
EP1540002A2 (en) * 2002-09-12 2005-06-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for detection of micro-metastasis
US7910295B2 (en) * 2002-11-14 2011-03-22 John Wayne Cancer Institute Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimarker quantitative RT-PCR
US20040101859A1 (en) 2002-11-25 2004-05-27 Cepheid Compositions, methods and kits for polynucleotide amplification reactions and microfluidic devices
WO2005055804A2 (en) * 2003-12-02 2005-06-23 Musc Foundation For Research Development Methods and compositions for diagnosing epithelial cell cancer
EP1774025A4 (en) * 2004-07-09 2009-09-16 Univ Pittsburgh IDENTIFYING MARKERS IN LUNG AND BREAST CANCER
JP2008515393A (ja) * 2004-09-20 2008-05-15 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 複数モードの多重化反応消去方法
US9032602B2 (en) 2011-07-15 2015-05-19 The Boeing Company Methods and systems for in-process quality control during drill-fill assembly

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011078223A1 (ja) * 2009-12-24 2011-06-30 国立大学法人愛媛大学 頸部リンパ節転移分析方法及び頭頸部癌の腫瘍マーカー
US8715931B2 (en) 2009-12-24 2014-05-06 National University Corporation Ehime University Method for analyzing cervical lymph node metastasis, and tumor marker for head and neck cancer
JP5807877B2 (ja) * 2009-12-24 2015-11-10 国立大学法人愛媛大学 頸部リンパ節転移分析方法及び頭頸部癌の腫瘍マーカー

Also Published As

Publication number Publication date
AU2005271961B8 (en) 2011-11-24
CA2571642A1 (en) 2006-02-16
EP2287329A2 (en) 2011-02-23
JP2012005500A (ja) 2012-01-12
EP1774030A2 (en) 2007-04-18
US20060068418A1 (en) 2006-03-30
AU2005271960A1 (en) 2006-02-16
US20060019290A1 (en) 2006-01-26
EP1774025A4 (en) 2009-09-16
US7662561B2 (en) 2010-02-16
EP2272987A2 (en) 2011-01-12
AU2005271960B2 (en) 2011-12-08
WO2006017151A3 (en) 2007-01-11
WO2006017150A2 (en) 2006-02-16
EP1774025A2 (en) 2007-04-18
EP2272987A3 (en) 2012-04-11
EP2468889A3 (en) 2012-07-11
CA2571650A1 (en) 2006-02-16
US20100240037A1 (en) 2010-09-23
EP2275578A2 (en) 2011-01-19
EP2275578A3 (en) 2011-11-30
AU2005271961B2 (en) 2011-10-13
EP2468889A2 (en) 2012-06-27
AU2005271961A1 (en) 2006-02-16
EP2287329A3 (en) 2011-08-03
EP1774030A4 (en) 2008-07-09
US20110312515A1 (en) 2011-12-22
WO2006017150A3 (en) 2009-04-09
JP2008510454A (ja) 2008-04-10
WO2006017151A2 (en) 2006-02-16

Similar Documents

Publication Publication Date Title
JP2012005500A (ja) 食道癌、結腸癌、頭頸部癌、およびメラノーマにおけるマーカーの同定
EP1272668B1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
US20230366034A1 (en) Compositions and methods for diagnosing lung cancers using gene expression profiles
US7767390B2 (en) Methods for evaluating drug-resistance gene expression in the cancer patient
JP2008515393A (ja) 複数モードの多重化反応消去方法
CN107858434B (zh) lncRNA在肝癌诊断以及预后预测中的应用
AU2005250479B2 (en) Diagnosing or predicting the course of breast cancer
WO2011104694A2 (en) Detection of braf v600e mutation by allele specific real time quantitative pcr (as-qpcr) using locked nucleic acids primers and beacon probes
CN101236193A (zh) 胃癌的淋巴结转移的检测
CN112813168B (zh) 一种与口腔鳞癌相关的生物标志物
WO2023145754A1 (ja) 膀胱癌の存在を検出するためのプライマー及びプローブ
WO2024204599A1 (ja) 膀胱癌のバイオマーカー
WO2024204603A1 (ja) 膀胱癌のバイオマーカー
AU2011253566A8 (en) Identification of markers in esophageal cancer, colon cancer, head and neck cancer and melanoma
BRPI1006640A2 (pt) métodos e reagentes para a detecção precoce de melanoma
HK1130514A (en) Diagnosing or predicting the course of breast cancer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080707

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080707

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110301

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110530

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110606

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110901

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20110907

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120222

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120508

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120515

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20121031